Show simple item record

dc.contributor.authorBarzegar, A
dc.contributor.authorMousavi, SJ
dc.contributor.authorHamidi, H
dc.contributor.authorSadeghi, M
dc.date.accessioned2018-08-26T07:18:50Z
dc.date.available2018-08-26T07:18:50Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/45385
dc.description.abstractThe protease of human immunodeficiency virus1 (HIV-PR) is an essential enzyme for antiviral treatments. Carbon nanostructures of fullerene derivatives, have nanoscale dimension with a diameter comparable to the diameter of the active site of HIV-PR which would in turn inhibit HIV. In this research, two dimensional quantitative structure-activity relationships (2D-QSAR) of fullerene derivatives against HIV-PR activity were employed as a powerful tool for elucidation the relationships between structure and experimental observations. QSAR study of 49 fullerene derivatives was performed by employing stepwise-MLR, GAPLS-MLR, and PCA-MLR models for variable (descriptor) selection and model construction. QSAR models were obtained with higher ability to predict the activity of the fullerene derivatives against HIV-PR by a correlation coefficient (R-training(2)) of 0.942, 0.89, and 0.87 as well as R-test(2) values of 0.791, 0.67and 0.674 for stepwise-MLR, GAPLS-MLR, and PCA-MLR models, respectively. Leave-one-out cross-validated correlation coefficient (R-2 CV) and Y-randomization methods confirmed the models robustness. The descriptors indicated that the HIV-PR inhibition depends on the van der Waals volumes, polarizability, bond order between two atoms and electronegativities of fullerenes derivatives. 2D-QSAR simulation without needing receptor's active site geometry, resulted in useful descriptors mainly denoting "C-60 backbone-functional groups" and "C-60 functional groups" properties. Both properties in fullerene refer to the ligand fitness and improvement van der Waals interactions with HIV-PR active site. Therefore, the QSAR models can be used in the search for novel HIV-PR inhibitors based on fullerene derivatives.
dc.language.isoEnglish
dc.relation.ispartofPHYSICA E-LOW-DIMENSIONAL SYSTEMS & NANOSTRUCTURES
dc.subjectFullerene nanostructure
dc.subjectHIV-1 protease
dc.subjectQSAR
dc.subjectPCA
dc.subjectGAPLS
dc.subjectMLR
dc.subjectRegression
dc.title2D-QSAR study of fullerene nanostructure derivatives as potent HIV-1 protease inhibitors
dc.typeArticle
dc.citation.volume93
dc.citation.spage324
dc.citation.epage331
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/j.physe.2017.06.016


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record